GALECTIN THERAPEUTICS INC Business Finance Contracts & Agreements

108 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
March 2025 Supplemental Line of Credit Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2025
November 2024 Supplemental Line of Credit Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2024
Supplemental Line of Credit Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein (March 29, 2024)
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2024
Convertible Promissory Note between Galectin Therapeutics, Inc. and Richard E. Uihlein (2024)
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2024
Restricted Stock Unit Agreement under Galectin Therapeutics Inc. 2019 Omnibus Equity Compensation Plan
Equity Distribution Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2024
Galectin Therapeutics Inc. Stock Option Agreement under 2019 Omnibus Equity Incentive Plan
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2024
Common Stock Purchase Warrant Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2024
Amendment and Restatement Agreement for Series B Common Stock Purchase Warrants between Galectin Therapeutics, Inc. and 10X Fund L.P./10X Capital Management LLC
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
FL
2024
Amendment to Deferred Stock Unit Agreement between Galectin Therapeutics Inc. and Joel Lewis under 2019 Omnibus Equity Compensation Plan
Modification Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2022
2023 Deferred Stock Unit Agreement between Galectin Therapeutics Inc. and Joel Lewis under the 2019 Omnibus Equity Compensation Plan
Equity Distribution Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2022
Convertible Promissory Note between Galectin Therapeutics, Inc. and Richard E. Uihlein (2022)
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2022
Line of Credit Letter Agreement between Richard E. Uihlein and Galectin Therapeutics, Inc. dated July 25, 2022
Financing Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2022
Common Stock Purchase Warrant Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2022
Unsecured Convertible Promissory Note between Galectin Therapeutics, Inc. and Richard E. Uihlein dated December 20, 2021
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2021
Galectin Therapeutics, Inc. Unsecured Convertible Promissory Note with Richard E. Uihlein dated September 17, 2021
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2021
Loan Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein dated September 17, 2021
Loan Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2021
Unsecured Convertible Promissory Note between Galectin Therapeutics, Inc. and Richard Uihlein dated April 16, 2021
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2021
Description of Galectin Therapeutics, Inc. Capital Stock as of March 31, 2021
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2021
Deferred Stock Unit Agreement under the Galectin Therapeutics Inc. 2019 Omnibus Equity Compensation Plan
Equity Distribution Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2020
Second Amendment to Line of Credit Letter Agreement between Richard E. Uihlein and Galectin Therapeutics, Inc.
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2019
Second Amended and Restated Common Stock Purchase Warrant (Class B) between Galectin Therapeutics, Inc. and 10X Fund, L.P.
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2019
Galectin Therapeutics, Inc. Second Amended and Restated Common Stock Purchase Warrant – Class B
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2019
Second Amendment to Common Stock Purchase Warrant between Galectin Therapeutics, Inc. and Richard E. Uihlein
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2019
First Amendment to Line of Credit Letter Agreement between Richard E. Uihlein and Galectin Therapeutics, Inc.
Modification Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2019
First Amendment to Common Stock Purchase Warrant between Galectin Therapeutics, Inc. and Richard E. Uihlein
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2019
Line of Credit Letter Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein dated December 19, 2017
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2017
Common Stock Purchase Warrant Agreement between Galectin Therapeutics, Inc. and Richard E. Uihlein
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2017
At Market Issuance Sales Agreement between Galectin Therapeutics Inc. and FBR Capital Markets & Co. dated May 19, 2017
Equity Distribution Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NJ
2017
Second Amendment to Securities Purchase Agreement between Galectin Therapeutics, Inc. and 10X Fund, L.P.
Purchase Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2016
Galectin Therapeutics, Inc. Subscription Agreement for Units Offering (2016)
Subscription Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2016
Galectin Therapeutics, Inc. Common Stock Purchase Warrant Agreement
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
Lock-Up Letter Agreement between Galectin Therapeutics Inc. and 10X Fund, L.P. (September 22, 2016)
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2016
Registration Rights Agreement between Galectin Therapeutics, Inc. and 10X Fund, L.P. (September 22, 2016)
Registration Rights Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
Securities Purchase Agreement between Galectin Therapeutics, Inc. and 10X Fund, L.P. dated September 22, 2016
Purchase Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
Common Stock Purchase Warrant Agreement (Class B-3) between Galectin Therapeutics, Inc. and 10X Fund, L.P.
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
Galectin Therapeutics, Inc. Class B-3 Common Stock Purchase Warrant Agreement with 10X Fund, L.P.
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
First Modification to Project Addendum for Protocol GT-026 between PPD Development, L.P. and Galectin Therapeutics, Inc.
Modification Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2016
Registration Rights Agreement between Galectin Therapeutics, Inc. and Purchasers (November 19, 2015)
Registration Rights Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2015
Placement Agency Agreement between Galectin Therapeutics Inc. and Roth Capital Partners, LLC (November 19, 2015)
Underwriting Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2015
Securities Purchase Agreement between Galectin Therapeutics, Inc. and Purchasers (November 19, 2015)
Purchase Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2015